Harte-Hanks, Inc. Common Stock
Here’s whether Harte-Hanks, Inc. Common Stock (HHS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); strong 1-year return of +30.7%; 3-month momentum positive (+54.7%); rising volume confirms the move (2.96x 30d avg). Concerns: 50-day MA is falling (-1.31% over 10 days); RSI 83 — overbought, elevated pullback risk. Currently 4.4% off its 52-week high. Score: +4/7.
HHS is in a confirmed uptrend, trading above both its 50-day ($2.43) and 200-day ($2.82) moving averages. With an RSI of 83.0, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +30.7% compares to +20.4% for SPY (beat the market by 10.3%).